Business
Schrödinger Provides Update on Progress Across the Business and Outlines 2026 Strategic Priorities
NEW YORK, January 12, 2026--Schrödinger, Inc. (Nasdaq: SDGR) provided an update on its progress across the business in 2025 and announced its strategic priorities for 2026. The company is continuing to focus on advancing its physics+AI computational platform and serving as a global leader in computational molecular discovery.
About this update from Schrodinger, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/73b253e389adb2f36486c9205e04b0bf"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/tmK8.O71RHOtt9LJgNBkZQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/73b253e389adb2f36486c9205e04b0bf","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/YUeftSo23xheepTq6uOAZw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/73b253e389adb2f36486c9205e04b0bf","width":1024,"height":512}},"lazy":false},{"type":"text","content":"NEW YORK, January 12, 2026--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) provided an update on its progress across the business in 2025 and announced its strategic priorities for 2026. The company is continuing to focus on advancing its physics+AI computational platform and serving as a global leader in computational molecular discovery.","length":344,"tagName":"p"},{"type":"text","content":""In 2025, we witnessed the continued impact of scaling ‘physics+AI’ to solve the challenges of data scarcity and to accelerate the discovery of differentiated molecules. We are entering 2026 with a clear mandate: to further strengthen our position as the essential design engine for the industry," stated Ramy Farid, Ph.D., chief executive officer at Schrödinger. "Our priorities for 2026 are focused on scaling our impact, maintaining scientific leadership, expanding the reach of our platform, advancing our collaborative portfolio of drug discovery programs, and securing development partners for our clinical programs. We are entering 2026 with strong momentum, highlighted by new strategic agreements with Lilly and Manas AI."","length":751,"tagName":"p"},{"type":"text","content":"Last week, Schrödinger announced that the Lilly TuneLab™ platform will be integrated into LiveDesign, Schrödinger’s widely used enterprise informatics solution. This allows users to combine Lilly’s federated learning models with Schrödinger’s physics-based simulations, solving the data scarcity problem that often hinders AI-driven discovery.","length":343,"tagName":"p"},{"type":"text","content":"Today Manas AI annou...